Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
2.
J Endocrinol Invest ; 28(10): 882-92, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16419490

ABSTRACT

OBJECTIVE: Neuroendocrine dysfunction in polycystic ovary syndrome (PCOS) was addressed by studying the steroid hormone changes in women with PCOS with either high or normal LH levels leading to inferences regarding the primacy of elevated LH in the pathophysiology of PCOS. METHODS: A cross-sectional study was designed in an academic clinical facility involving 234 women with PCOS. Patients were divided into two groups based on an LH/FSH ratio < or >1 and hormonal and metabolic studies were performed in both groups. Factors were determined by binomial logistic regression that predicted group membership of these women. RESULTS: Higher follicular phase estradiol (E2) and androstenedione (A4) levels as well as greater insulin sensitivity were the only factors that predicted the presence of neuroendocrine dysfunction with elevated A4 being necessary for neuroendocrine dysfunction. CONCLUSIONS: It was concluded that uncoupling of hypothalamic E2 inhibition by elevated ovarian A4 associated with E2 related sensitization of pituitary LH leads to neuroendocrine dysfunction in PCOS.


Subject(s)
Androstenedione/blood , Estradiol/blood , Neurosecretory Systems/physiopathology , Polycystic Ovary Syndrome/physiopathology , 17-alpha-Hydroxyprogesterone/blood , Adolescent , Adult , Androstenedione/physiology , Blood Glucose/analysis , Body Mass Index , Cross-Sectional Studies , Estradiol/physiology , Female , Follicle Stimulating Hormone/blood , Homeostasis , Humans , Hypothalamus/physiopathology , Insulin/blood , Insulin Resistance/physiology , Luteinizing Hormone/blood , Obesity/physiopathology , Pituitary Gland/physiopathology , Polycystic Ovary Syndrome/blood , Regression Analysis , Testosterone/blood
3.
Clin Exp Allergy ; 34(8): 1192-201, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15298558

ABSTRACT

BACKGROUND: A recent report provided evidence that a disintegrin and metalloprotease domain 33 (ADAM33), a member of the ADAM family, is a novel susceptibility gene in asthma linked to bronchial hyper-responsiveness. However, there has been no investigation of the genetic role of ADAM33 variants in nasal allergy. OBJECTIVE: The purpose of this study was to test the association between ADAM33 polymorphisms and Japanese cedar pollinosis (JCPsis), a most common seasonal allergic rhinitis in Japan. METHODS: We conducted a case-control association study among a Japanese population, involving 95 adult individuals with JCPsis and 95 normal healthy controls. A total of 22 single-nucleotide polymorphisms (SNPs) in ADAM33 were genotyped using PCR-based molecular methods. RESULTS: Six SNPs of ADAM33 gene, three in introns (7575G/A, 9073G/A and 12540C/T) and three in the coding region (10918G/C, 12433T/C and 12462C/T), were strongly associated with JCPsis (P = 0.0002-0.022 for absolute allele frequencies) and most of the SNPs were in linkage disequilibrium with each other. A higher frequency of the common alleles of these SNPs was noted for the subjects with JCPsis in comparison with healthy controls. We also identified a haplotype associated with the disease susceptibility. In addition, associations were found between ADAM33 polymorphisms and various cedar pollinosis phenotypes including clinical severity, eosinophil counts in nasal secretion and allergen-specific IgE levels in sera, but not total serum IgE levels. CONCLUSION: These results indicate that polymorphisms in the ADAM33 gene are associated with susceptibility to allergic rhinitis due to Japanese cedar pollen, but the functional relationship still needs clarification.


Subject(s)
Cryptomeria , Metalloendopeptidases/genetics , Pollen , Polymorphism, Single Nucleotide , Rhinitis, Allergic, Seasonal/genetics , ADAM Proteins , Adult , Case-Control Studies , Chi-Square Distribution , Genetic Predisposition to Disease , Genotype , Humans , Japan , Linkage Disequilibrium , Polymorphism, Restriction Fragment Length , Sequence Analysis, DNA
4.
Bioresour Technol ; 95(2): 129-34, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15246436

ABSTRACT

Extraction of flavonoids from Japanese larch (Larix leptolepis) wood with water was carried out to prepare a termite feeding deterrent. A two-stage procedure for the extraction was adopted. The first extraction step was performed at ambient temperature (22 degrees C) and the second at elevated temperatures ranging 50-100 degrees C. The first step mainly gave a mixture of polysaccharides together with small amount of flavonoids. At the second step, the yield of extract and its chemical composition were greatly affected by the temperature. The yield of solubilised carbohydrates steadily increased with a rise in the temperature, while the overall yield of flavonoids reached its optimum at 70 degrees C. An additional increase in the temperature resulted in a decrease in the yield. Model experiments using dihydroflavonols confirmed the occurrence of oxidative dehydrogenation and/or intramolecular rearrangement during the hydrothermal treatment at higher temperatures. The crude water extracts showed strong feeding deterrent activities against the subterranean termite, Coptotermes formosanus, in a choice paper disc assay. The extracts containing flavonoids in large quantities exhibited potent termite feeding deterrent activities.


Subject(s)
Feeding Behavior/drug effects , Flavonoids/toxicity , Isoptera/drug effects , Larix/chemistry , Animals , Feeding Behavior/physiology , Flavonoids/chemistry , Isoptera/physiology , Japan , Models, Chemical , Plant Extracts/chemistry , Plant Extracts/toxicity , Temperature , Time Factors
5.
Int J Cancer ; 94(4): 545-50, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11745442

ABSTRACT

ROIs and their scavengers are associated with apoptosis induction by anticancer drugs and gamma-rays, but the details have not been clarified. We examined the effect of transfection of Mn-SOD antisense on apoptosis by 5-FU, PLM, CDDP and gamma-rays using nu/nu mice. After inoculation of Mn-SOD antisense-transfected SCC cells into the subcutis of each mouse's back, they slowly multiplied to form tumors sized 1,460 +/- 70 mm(3) at day 60, while control vector-transfected SCC cells rapidly multiplied, with a mean tumor size of 2,330 +/- 220 mm(3). Inversely, mice in the Mn-SOD antisense group survived longer (mean survival duration 94.4 +/- 12.7 days) compared to those in the empty vector group (67.3 +/- 6.8 days). After treatment with 5-FU (5 microg/day), PLM (50 microg/day), CDDP (10 microg/day) and gamma-rays (2 Gy/day), mean survival times were largely prolonged, to 126.3 +/- 22.7, 123.0 +/- 22.1, 136.3 +/- 24.0 and 143.0 +/- 20.8 days, respectively, while mean survival times in the empty vector group were 91.7 +/- 14.8, 85.7 +/- 13.3, 97.5 +/- 16.0 and 100.7 +/- 17.1 days, respectively. Immunohistologically, tumors in the Mn-SOD antisense group revealed additional nick end-labeled cells compared to those in the empty vector group. In comparison, strong expression of Bax, Bak and p21(waf1/cip1) and suppressed expression of Bcl-2, Bcl-X(L) and COX-2 were observed in the Mn-SOD antisense group and the expression pattern of these proteins was the inverse in the empty vector group. The increased expression of these proapoptotic proteins appeared to be p53-independent because p53 protein expression was not increased in the antisense group. These immunohistologic results were supported by Western blotting of each protein. In conclusion, Mn-SOD antisense transfection is advantageous for apoptosis induction of SCC cells by anticancer drugs and gamma-rays through induction of proapoptotic Bcl-2 family proteins and suppression of antiapoptotic protein expression.


Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis , Carcinoma, Squamous Cell/drug therapy , Carcinoma, Squamous Cell/metabolism , Cyclins/metabolism , Gamma Rays , Isoenzymes/metabolism , Oligonucleotides, Antisense/pharmacology , Prostaglandin-Endoperoxide Synthases/metabolism , Proto-Oncogene Proteins c-bcl-2/metabolism , Superoxide Dismutase/genetics , Superoxide Dismutase/physiology , Up-Regulation , Animals , Antibiotics, Antineoplastic/therapeutic use , Antimetabolites, Antineoplastic/therapeutic use , Antineoplastic Agents/therapeutic use , Blotting, Western , Cisplatin/therapeutic use , Cyclin-Dependent Kinase Inhibitor p21 , Cyclooxygenase 2 , DNA, Complementary/metabolism , Fluorouracil/therapeutic use , Genetic Vectors , Humans , Immunohistochemistry , In Situ Nick-End Labeling , Membrane Proteins , Mice , Mice, Nude , Neoplasm Transplantation , Peplomycin/therapeutic use , Reverse Transcriptase Polymerase Chain Reaction , Superoxide Dismutase/metabolism , Time Factors , Transfection , Tumor Cells, Cultured
6.
Clin Endocrinol (Oxf) ; 52(6): 765-73, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10848882

ABSTRACT

AIMS: To compare the efficacy of remnant ablation following a single low dose (specific activity of 131I administered, 1074-1110 MBq) vs. a single high dose (mostly 2775-3700 MBq) of 131I in patients with differentiated thyroid cancer and to determine whether or not the extent of surgery influences outcome. METHODS: Nineteen studies have reported the results of low dose 131I ablation. Of these, 11 met our criteria for a comparative analysis. Two additional cohorts of ours were added and these were analysed in two groups based on the extent of surgery (near-total [NT; Woodhouse1] vs. sub-total [ST; Woodhouse2]). There were 518 low dose and 449 high dose patients in all. RESULTS: The average failure of a single low dose was 46 +/- 28% (SD). Meta-analysis revealed a statistically significant advantage for a single high over a single low dose and a pooled reduction in relative risk of failure of the high dose of about 27% (P < 0.01). From this we estimate that for every seven patients treated one more would be ablated given a high rather than a low dose (assuming a low dose failure risk of 50%). Also, a significantly greater proportion of patients are ablated after a single high or low dose, if they underwent near-total as opposed to sub-total thyroidectomy (summary relative risk (RR) 1.4; P < 0.05). CONCLUSION: High dose 131I is more efficient than low dose for remnant ablation particularly after less than total thyroidectomy. Results suggest that patients with differentiated thyroid cancer should routinely have a total thyroidectomy followed by high dose 131I (2775-3700MBq) for ablation of the remnant.


Subject(s)
Iodine Radioisotopes/administration & dosage , Thyroid Neoplasms/radiotherapy , Cohort Studies , Combined Modality Therapy , Humans , Iodine Radioisotopes/therapeutic use , Radiotherapy Dosage , Randomized Controlled Trials as Topic , Risk , Thyroid Gland/radiation effects , Thyroid Neoplasms/surgery , Thyroidectomy/methods , Treatment Failure
SELECTION OF CITATIONS
SEARCH DETAIL